Mathuri Santhi-Morgan, Industry Advocate, Media & Marketing Advisor at Vox Hero, and Member of the Board of Directors at Bridging Lanka Ltd (Australia), shared a post by ACORES, on LinkedIn, adding:
“Reposting for colleagues across oncology, cardiology, primary care, nursing, pharmacy and survivorship care.
ACORES – THE INAUGURAL AUSTRALIAN CARDIO-ONCOLOGY RESEARCH & EDUCATION SYMPOSIUM ACORES 2026
Cardio Oncology is emerging as a significant systems challenge. As cancer survival improves, more patients are presenting with treatment‑related cardiovascular complications, and current models of care are struggling to meet this growing need. This is no longer a theoretical concern – it is shaping everyday clinical practice across multiple disciplines.
ACORES 2026 brings together national and international leaders to examine this issue through a practical, multidisciplinary lens, focusing on early detection, risk assessment, survivorship planning and real‑world case discussions.
The goal is clear: improve coordination and outcomes for patients who sit at the intersection of cancer and cardiovascular disease. Capacity is limited, and registrations are moving quickly. Event details.
For clinicians in regional and rural areas, your participation is vital to ensuring this discussion reflects the realities of care across Australia. Australian Government Department of Health, Disability and Ageing offers programs that may support travel and professional development.
We want this information to reach as many clinicians as possible – please share it widely. If cost is a barrier, reach out, we are committed to supporting attendance wherever we can.
This is a crucial moment for Australia to align on a coordinated, multidisciplinary approach to a rapidly evolving area of practice.
Featuring experts including: Aaron Sverdlov, Doan Ngo, Daniel Chen, Mark Nolan, Satish Ramkumar, Jarad Martin, Prof. Linda Worrall-Carter, and others.
Proudly supported by: Racura Oncology, Cipla, AstraZeneca, Novartis, MENARINI Group, Her Heart Charity, Cardiac Society of Australia and New Zealand, NSW Cardiovascular Research Network (CVRN), NSW Regional Cancer Research Network, Cancer Council Australia, Cancer Council NSW, International Cardio-Oncology Society.
More details are available here.”
Quoting ACORES‘s post:
“Tickets for ACORES 2026 are selling fast as clinicians across Australia and beyond prepare to join us for two days of high-impact, evidence-based education in cardio‑oncology and survivorship care.
This year’s program brings together multi-disciplinary leading experts, delivering practical, clinically relevant insights across:
– Emerging models of cardio-oncology care
– Survivorship pathways and multidisciplinary coordination
– Cardiotoxicity management
– Complex case discussions
Innovations in imaging, biomarkers, and risk stratification.
Whether you’re an oncologist, cardiologist, GP, nurse, pharmacist, or allied health professional, ACORES 2026 offers a rare opportunity to deepen your expertise and strengthen collaborative care for patients navigating cancer and cardiovascular risk.
Secure your place before tickets sell out”
Other articles on Cardio Oncology on OncoDaily.